Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Jun 16, 2023 | Sale | $18.88 | 2,286 | 43,160 | 25,987 | Jun 20, 2023, 05:06 PM | |
QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Feb 28, 2022 | Sale | $16.70 | 602 | 10,053 | 10,877 | Mar 02, 2022, 05:39 PM | |
QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Mar 02, 2021 | Sale | $37.50 | 505 | 18,938 | 9,945 | Mar 04, 2021, 01:53 PM | |
QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Jan 28, 2020 | Sale | $62.19 | 807 | 50,190 | 6,808 | Jan 30, 2020, 08:57 PM | |
SYRS | Syros Pharmaceuticals, Inc. | Springhorn Jeremy P. | Chief Business Officer | Nov 11, 2019 | Buy | $4.99 | 9,879 | 49,328 | 24,879 | Nov 12, 2019, 04:34 PM | |
SYRS | Syros Pharmaceuticals, Inc. | Springhorn Jeremy P. | Chief Business Officer | Nov 12, 2019 | Buy | $4.97 | 10,121 | 50,268 | 35,000 | Nov 12, 2019, 04:34 PM | |
QURE | uniQure N.V. | Springhorn Jeremy P. | Director | Jan 28, 2019 | Sale | $31.32 | 1,210 | 37,897 | 6,812 | Jan 30, 2019, 04:49 PM | |
SYRS | Syros Pharmaceuticals, Inc. | Springhorn Jeremy P. | Chief Business Officer | Dec 15, 2017 | Buy | $9.08 | 15,000 | 136,260 | 15,000 | Dec 15, 2017, 04:02 PM |